Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
02 2022
Historique:
received: 01 10 2020
accepted: 01 07 2021
revised: 22 06 2021
pubmed: 18 7 2021
medline: 16 4 2022
entrez: 17 7 2021
Statut: ppublish

Résumé

Globally, 2.2 billion people live with some form of vision impairment and/or eye disease. To date, most systematic reviews examining associations have focused on a single eye disease and there is no systematic evaluation of the relationships between eye diseases and diverse physical and mental health outcomes. Moreover, the strength and reliability of the literature is unclear. We performed an umbrella review of observational studies with meta analyses for any physical and/or mental comorbidities associated with eye disease. For each association, random-effects summary effect size, heterogeneity, small-study effect, excess significance bias and 95% prediction intervals were calculated, and used to grade significant evidence from convincing to weak. 34 studies were included covering 58 outcomes. No outcomes yielded convincing evidence, six outcomes yielded highly suggestive results (cataract positively associated with type 2 diabetes, open-angled glaucoma positively associated with myopia and diabetes, diabetic retinopathy positively associated with cardiovascular disease and cardiovascular mortality, and retinopathy of prematurity positively associated with chorioamnionitis), eight outcomes yielded suggestive results (diabetic retinopathy positively associated with all-cause mortality and depression, diabetic macular oedema positively associated with dyslipidaemia, cataract positively associated with gout, nuclear sclerosis positively associated with all-cause mortality, open angled glaucoma positively associated with migraine and hypertension, and age-related macular degeneration positively associated with diabetes), and 18 outcomes yielded weak evidence. Results show highly suggestive or suggestive evidence for associations between several types of eye diseases with several comorbid outcomes. Practitioners and public health policies should note these findings when developing healthcare policies. 摘要: 全球22亿人患有视力障碍和/或各种眼疾。到目前为止, 大多数系统综述都是针对眼病而进行的, 没有系统地评价眼病与各种生理和心理健康结果之间的关系。此外, 文献的影响力和可靠性尚不清楚。我们对与眼病相关的任何全身和/或精神共患疾病的meta分析的观察性研究进行了伞形评价。对于每项研究, 我们都计算了随机效应的总效应量、异质性、小型研究效应、显著性偏差和95%的可信区间, 并将显著性证据等级从信服到较弱进行了划分。共纳入34项研究, 包括58项结果。其中没有一项结果的证据等级达到信服, 6个结果的证据等级达到高度有意义 (白内障与2型糖尿病正相关, 开角型青光眼与近视和糖尿病正相关, 糖尿病视网膜病变与心血管疾病和心血管死亡率正相关, 早产儿视网膜病变与绒毛膜羊膜炎呈正相关, 8项结果的证据等级为有意义 (糖尿病视网膜病变与全因死亡率和抑郁呈正相关, 糖尿病黄斑水肿与血脂异常呈正相关, 白内障与痛风呈正相关, 核硬化与全因死亡率呈正相关, 开角型青光眼与偏头痛和高血压呈正相关, 年龄相关性黄斑变性与糖尿病呈正相关, 18项结果的证据不足。结果显示多种眼病与多种共患疾病之间的相关性为高度有意义或有意义等级的证据。相关人员在制定公共卫生保健政策时应注意这些发现。.

Autres résumés

Type: Publisher (chi)
摘要: 全球22亿人患有视力障碍和/或各种眼疾。到目前为止, 大多数系统综述都是针对眼病而进行的, 没有系统地评价眼病与各种生理和心理健康结果之间的关系。此外, 文献的影响力和可靠性尚不清楚。我们对与眼病相关的任何全身和/或精神共患疾病的meta分析的观察性研究进行了伞形评价。对于每项研究, 我们都计算了随机效应的总效应量、异质性、小型研究效应、显著性偏差和95%的可信区间, 并将显著性证据等级从信服到较弱进行了划分。共纳入34项研究, 包括58项结果。其中没有一项结果的证据等级达到信服, 6个结果的证据等级达到高度有意义 (白内障与2型糖尿病正相关, 开角型青光眼与近视和糖尿病正相关, 糖尿病视网膜病变与心血管疾病和心血管死亡率正相关, 早产儿视网膜病变与绒毛膜羊膜炎呈正相关, 8项结果的证据等级为有意义 (糖尿病视网膜病变与全因死亡率和抑郁呈正相关, 糖尿病黄斑水肿与血脂异常呈正相关, 白内障与痛风呈正相关, 核硬化与全因死亡率呈正相关, 开角型青光眼与偏头痛和高血压呈正相关, 年龄相关性黄斑变性与糖尿病呈正相关, 18项结果的证据不足。结果显示多种眼病与多种共患疾病之间的相关性为高度有意义或有意义等级的证据。相关人员在制定公共卫生保健政策时应注意这些发现。.

Identifiants

pubmed: 34272511
doi: 10.1038/s41433-021-01684-x
pii: 10.1038/s41433-021-01684-x
pmc: PMC8807837
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

369-378

Informations de copyright

© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Références

World Health Organization. Blindness and vision impairment: The key facts. 2019. https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment . Accessed May 6, 2020.
Bourne RR, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e888–e897.
pubmed: 28779882 doi: 10.1016/S2214-109X(17)30293-0
Fricke TR, Tahhan N, Resnikoff S, Papas E, Burnett A, Ho SM, et al. Global prevalence of presbyopia and vision impairment from uncorrected presbyopia: systematic review, meta-analysis, and modelling. Ophthalmology. 2018;125:1492–9.
pubmed: 29753495 doi: 10.1016/j.ophtha.2018.04.013
Swenor BK, Simonsick EM, Ferrucci L, Newman AB, Rubin S, Wilson V, et al. Visual impairment and incident mobility limitations: the health, aging and body composition study. J Am Geriatr Soc. 2015;63:46–54.
pubmed: 25536849 doi: 10.1111/jgs.13183
Chen Y-J, Yeung L, Sun C-C, Huang C-C, Chen K-S, Lu Y-H. Age-related macular degeneration in chronic kidney disease: a meta-analysis of observational studies. Am J Nephrol. 2018;48:278–91.
pubmed: 30336463 doi: 10.1159/000493924
Luo C, Chen X, Jin H, Yao K. The association between gout and cataract risk: a meta-analysis. PloS One. 2017;12:e0180188.
pubmed: 28662131 pmcid: 5491146 doi: 10.1371/journal.pone.0180188
Shi Y, Liu P, Guan J, Lu Y, Su K. Association between glaucoma and obstructive sleep apnea syndrome: a meta-analysis and systematic review. PloS One. 2015;10:e0115625–e0115625.
pubmed: 25705901 pmcid: 4338237 doi: 10.1371/journal.pone.0115625
Choi HG, Lee MJ, Lee S-M. Visual impairment and risk of depression: a longitudinal follow-up study using a national sample cohort. Sci Rep. 2018;8:2083.
pubmed: 29391510 pmcid: 5794974 doi: 10.1038/s41598-018-20374-5
Hong T, Mitchell P, Burlutsky G, Liew G, Wang JJ. Visual impairment, hearing loss and cognitive function in an older population: longitudinal findings from the Blue Mountains Eye Study. PLoS One. 2016;11:e0147646.
pubmed: 26808979 pmcid: 4726694 doi: 10.1371/journal.pone.0147646
Meyer-Rochow VB, Hakko H, Ojamo M, Uusitalo H, Timonen M. Suicides in visually impaired persons: a nation-wide register-linked study from finland based on thirty years of data. PloS One. 2015;10:e0141583–e0141583.
pubmed: 26509899 pmcid: 4624868 doi: 10.1371/journal.pone.0141583
Rajala U, Pajunpää H, Koskela P, Keinänen-Kiukaanniemi S. High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. Diabetes Care. 2000;23:957.
pubmed: 10895846 doi: 10.2337/diacare.23.7.957
McCarty CA, Nanjan MB, Taylor HR. Vision impairment predicts 5 year mortality. Br J Ophthalmol. 2001;85:322–6.
pubmed: 11222339 pmcid: 1723877 doi: 10.1136/bjo.85.3.322
Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181:488–93.
pubmed: 19654195 pmcid: 2761440 doi: 10.1503/cmaj.081086
Ioannidis J. Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews. Br J Sports Med. 2017;51:1456–8.
pubmed: 28223307 doi: 10.1136/bjsports-2017-097621
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Health. 2015;13:132–40.
doi: 10.1097/XEB.0000000000000055
Radua J, Ramella‐Cravaro V, Ioannidis JP, Reichenberg A, Phiphopthatsanee N, Amir T, et al. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018;17:49–66.
pubmed: 29352556 pmcid: 5775150 doi: 10.1002/wps.20490
Raglan O, Kalliala I, Markozannes G, Cividini S, Gunter MJ, Nautiyal J, et al. Risk factors for endometrial cancer: an umbrella review of the literature. Int J Cancer. 2019;145:1719–30.
pubmed: 30387875 doi: 10.1002/ijc.31961
Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.
pubmed: 24690624 pmcid: 3972415 doi: 10.1136/bmj.g2035
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.
pubmed: 28935701 pmcid: 5833365 doi: 10.1136/bmj.j4008
Veronese N, Solmi M, Caruso MG, Giannelli G, Osella AR, Evangelou E, et al. Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr. 2018;107:436–44.
pubmed: 29566200 doi: 10.1093/ajcn/nqx082
Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, et al. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020;59:263–72.
pubmed: 30684032 doi: 10.1007/s00394-019-01905-w
Machado MO, Veronese N, Sanches M, Stubbs B, Koyanagi A, Thompson T, et al. The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2018;16:1–13.
doi: 10.1186/s12916-018-1101-z
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
pubmed: 3802833 doi: 10.1016/0197-2456(86)90046-2
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
pubmed: 12958120 pmcid: 192859 doi: 10.1136/bmj.327.7414.557
Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.
pubmed: 21310794 doi: 10.1136/bmj.d549
Bortolato B, Köhler CA, Evangelou E, León‐Caballero J, Solmi M, Stubbs B, et al. Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta‐analyses. Bipolar Disord. 2017;19:84–96.
pubmed: 28470927 doi: 10.1111/bdi.12490
Dragioti E, Evangelou E, Larsson B, Gerdle B. Effectiveness of multidisciplinary programmes for clinical pain conditions: an umbrella review. J Rehabil Med. 2018;50:779–91.
pubmed: 30132012 doi: 10.2340/16501977-2377
Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4:245–53.
pubmed: 17715249 doi: 10.1177/1740774507079441
Ioannidis JP. Clarifications on the application and interpretation of the test for excess significance and its extensions. J Math Psychol. 2013;57:184–7.
doi: 10.1016/j.jmp.2013.03.002
Dragioti E, Karathanos V, Gerdle B, Evangelou E. Does psychotherapy work? An umbrella review of meta‐analyses of randomized controlled trials. Acta Psychiatr Scand. 2017;136:236–46.
pubmed: 28240781 doi: 10.1111/acps.12713
Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis JP. et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376
pubmed: 28592419 pmcid: 5461476 doi: 10.1136/bmj.j2376
Akbari M, Akbari S, Pasquale LR. The association of primary open-angle glaucoma with mortality: a meta-analysis of observational studies. Arch Ophthalmol. 2009;127:204–10.
pubmed: 19204241 doi: 10.1001/archophthalmol.2008.571
Marcus MW, de Vries MM, Junoy Montolio FG, Jansonius NM. Myopia as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. Ophthalmology. 2011;118:1989–94.e2.
pubmed: 21684603 doi: 10.1016/j.ophtha.2011.03.012
Li L, Wan X, Zhao G. Meta-analysis of the risk of cataract in type 2 diabetes. BMC Ophthalmol. 2014;14:94.
pubmed: 25060855 pmcid: 4113025 doi: 10.1186/1471-2415-14-94
Chen X, Jhanji V, Chen C, Chen H. Serological association of Chlamydia pneumoniae infection with age-related macular degeneration: a systematic review and meta-analysis. PloS One. 2014;9:e103466.
pubmed: 25062085 pmcid: 4111616 doi: 10.1371/journal.pone.0103466
Zhou M, Wang W, Huang W, Zhang X. Diabetes mellitus as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. PloS One. 2014;9:e102972.
pubmed: 25137059 pmcid: 4138056 doi: 10.1371/journal.pone.0102972
Bae HW, Lee N, Lee HS, Hong S, Seong GJ, Kim CY. Systemic hypertension as a risk factor for open-angle glaucoma: a meta-analysis of population-based studies. PloS One. 2014;9:e108226.
pubmed: 25254373 pmcid: 4177901 doi: 10.1371/journal.pone.0108226
Zhao D, Cho J, Kim MH, Friedman DS, Guallar E. Diabetes, fasting glucose, and the risk of glaucoma: a meta-analysis. Ophthalmology. 2015;122:72–78.
pubmed: 25283061 doi: 10.1016/j.ophtha.2014.07.051
Song E, Sun H, Xu Y, Ma Y, Zhu H, Pan C-W. Age-related cataract, cataract surgery and subsequent mortality: a systematic review and meta-analysis. PloS One. 2014;9:e112054.
pubmed: 25369040 pmcid: 4219834 doi: 10.1371/journal.pone.0112054
Au SCL, Tang S-M, Rong S-S, Chen L-J, Yam JCS. Association between hyperglycemia and retinopathy of prematurity: a systemic review and meta-analysis. Sci Rep. 2015;5:9091.
pubmed: 25766465 pmcid: 4357868 doi: 10.1038/srep09091
Das R, Kerr R, Chakravarthy U, Hogg RE. Dyslipidemia and diabetic macular edema: a systematic review and meta-analysis. Ophthalmology. 2015;122:1820–7.
pubmed: 26150053 doi: 10.1016/j.ophtha.2015.05.011
Fernandez AB, Panza GA, Cramer B, Chatterjee S, Jayaraman R, Wu W-C. Age-related macular degeneration and incident stroke: a systematic review and meta-analysis. PloS One. 2015;10:e0142968.
pubmed: 26580396 pmcid: 4651536 doi: 10.1371/journal.pone.0142968
Zhou L-X, Sun C-L, Wei L-J, Gu Z-M, Lv L, Dang Y. Lower cognitive function in patients with age-related macular degeneration: a meta-analysis. Clin Interv Aging 2016;11:215–23.
pubmed: 26966358 pmcid: 4771401
Chan PYL, Tang S-M, Au SCL, Rong S-S, Lau HHW, Ko STC, et al. Association of gestational hypertensive disorders with retinopathy of prematurity: a systematic review and meta-analysis. Sci Rep. 2016;6:30732.
pubmed: 27491726 pmcid: 4974497 doi: 10.1038/srep30732
Wang J, Xue Y, Thapa S, Wang L, Tang J, Ji K. Relation between age-related macular degeneration and cardiovascular events and mortality: a systematic review and meta-analysis. BioMed Res Int. 2016;2016:8212063.
pubmed: 28070519 pmcid: 5192308 doi: 10.1155/2016/8212063
Zhu X-R, Zhang Y-P, Bai L, Zhang X-L, Zhou J-B, Yang J-K. Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure: Evidence from epidemiological observational studies. Medicine. 2017;96:e5894.
pubmed: 28099347 pmcid: 5279092 doi: 10.1097/MD.0000000000005894
McGuinness MB, Karahalios A, Finger RP, Guymer RH, Simpson JA. Age-related macular degeneration and mortality: a systematic review and meta-analysis. Ophthalmic Epidemiol. 2017;24:141–52.
pubmed: 28139151 doi: 10.1080/09286586.2016.1259422
Zhou Y, Zhang Y, Shi K, Wang C. Body mass index and risk of diabetic retinopathy: a meta-analysis and systematic review. Medicine. 2017;96:e6754.
pubmed: 28562529 pmcid: 5459694 doi: 10.1097/MD.0000000000006754
Xu C, Li J, Li Z, Mao X. Migraine as a risk factor for primary open angle glaucoma: a systematic review and meta-analysis. Medicine. 2018;97:e11377.
pubmed: 29995778 pmcid: 6076184 doi: 10.1097/MD.0000000000011377
Zhou Y, Wang C, Shi K, Yin X. Relationship between dyslipidemia and diabetic retinopathy: a systematic review and meta-analysis. Medicine. 2018;97:e12283.
pubmed: 30200172 pmcid: 6133445 doi: 10.1097/MD.0000000000012283
Zhou Y, Wang C, Shi K, Yin X. Relation of metabolic syndrome and its components with risk of diabetic retinopathy: a meta-analysis of observational studies. Medicine. 2018;97:e12433.
pubmed: 30235724 pmcid: 6160146 doi: 10.1097/MD.0000000000012433
Villamor-Martinez E, Cavallaro G, Raffaeli G, Mohammed Rahim OMM, Gulden S, Ghazi AMT, et al. Chorioamnionitis as a risk factor for retinopathy of prematurity: An updated systematic review and meta-analysis. PloS One. 2018;13:e0205838.
pubmed: 30332485 pmcid: 6192636 doi: 10.1371/journal.pone.0205838
Huang J, Tang Y, Zhu T, Li Y, Chun H, Qu Y, et al. Cumulative evidence for association of sepsis and retinopathy of prematurity. Medicine. 2019;98:e17512.
pubmed: 31626109 pmcid: 6824763 doi: 10.1097/MD.0000000000017512
Huon L-K, Liu SY-C, Camacho M, Guilleminault C. The association between ophthalmologic diseases and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2016;20:1145–54.
pubmed: 27230013 doi: 10.1007/s11325-016-1358-4
Druet-Cabanac M, Boussinesq M, Dongmo L, Farnarier G, Bouteille B, Preux PM. Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology. 2004;23:144–9.
pubmed: 15084784 doi: 10.1159/000075958
Wu C, You Z. Meta-analysis of the relationship between depression and diabetic retinopathy. Biomed Res. 2018;29:0970–938X.
doi: 10.4066/biomedicalresearch.29-17-2963
Xin X, Sun Y, Li S, Xu H, Zhang D. Age-related macular degeneration and the risk of all-cause and cardiovascular mortality: a meta-analysis of cohort studies. Retina. 2018; 38. https://journals.lww.com/retinajournal/Fulltext/2018/03000/AGE_RELATED_MACULAR_DEGENERATION_AND_THE_RISK_OF.7.aspx .
Wang X, Tang L, Gao L, Yang Y, Cao D, Li Y. Myopia and diabetic retinopathy: a systematic review and meta-analysis. Diabetes Res Clin Pr. 2016;111:1–9.
doi: 10.1016/j.diabres.2015.10.020
Guo VY, Cao B, Wu X, Lee JJW, Zee BC. Prospective association between diabetic retinopathy and cardiovascular disease—a systematic review and meta-analysis of cohort studies. J Stroke Cerebrovasc Dis. 2016;25:1688–95.
pubmed: 27068777 doi: 10.1016/j.jstrokecerebrovasdis.2016.03.009
Chatziralli IP, Sergentanis TN. Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology. 2011;118:730–5.
pubmed: 21168223 doi: 10.1016/j.ophtha.2010.08.039
Song D, Li C, Wang Z, Zhao Y, Shen B, Zhao W. Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: a meta‐analysis of observational studies. J Diabetes Investig. 2020.
Xu X-H, Sun B, Zhong S, Wei D-D, Hong Z, Dong A-Q. Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis. BMC Cardiovasc Disord. 2020;20:1–8.
doi: 10.1186/s12872-020-01763-z
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63:618–37.
pubmed: 29679617 pmcid: 6089661 doi: 10.1016/j.survophthal.2018.04.002
Oh J-W, Park C-W, Moon KC, Park JS, Jun JK. The relationship among the progression of inflammation in umbilical cord, fetal inflammatory response, early-onset neonatal sepsis, and chorioamnionitis. PloS One. 2019;14:e0225328–e0225328.
pubmed: 31743377 pmcid: 6863554 doi: 10.1371/journal.pone.0225328
Bolinger MT, Antonetti DA. Moving past anti-VEGF: novel therapies for treating diabetic retinopathy. Int. J. Mol. Sci. 2016;17:1498.
pmcid: 5037775 doi: 10.3390/ijms17091498
Tsai T, Kuehn S, Tsiampalis N, Vu M-K, Kakkassery V, Stute G, et al. Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients. PloS One. 2018;13:e0194603–e0194603.
pubmed: 29584759 pmcid: 5870958 doi: 10.1371/journal.pone.0194603
Domingueti CP, Dusse LMS, das Graças Carvalho M, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat. 2016;30:738–45.
doi: 10.1016/j.jdiacomp.2015.12.018
Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. Vascular complications of diabetes. BMJ. 2000;320:1062–6.
pubmed: 10764371 pmcid: 1117946 doi: 10.1136/bmj.320.7241.1062
Kern TS, Barber AJ. Retinal ganglion cells in diabetes. J Physiol. 2008;586:4401–8.
pubmed: 18565995 pmcid: 2614025 doi: 10.1113/jphysiol.2008.156695
Ioannidis JPA. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q. 2016;94:485–514.
pubmed: 27620683 pmcid: 5020151 doi: 10.1111/1468-0009.12210

Auteurs

Mike Trott (M)

Vision and Eye Research Institute (VERI), School of Medicine, Anglia Ruskin University, Cambridge, UK. mike.trott@aru.ac.uk.
The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK. mike.trott@aru.ac.uk.

Lee Smith (L)

The Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University, Cambridge, UK.

Nicola Veronese (N)

National Research Council, Neuroscience Institute, Aging Branch, Padua, Italy.
University of Palermo, Department of Geriatrics, Palermo, Italy.

Damiano Pizzol (D)

Italian Agency for Development Cooperation (Khartoum), Khartoum, Sudan.

Yvonne Barnett (Y)

School of Life Sciences, Anglia Ruskin University, Cambridge, UK.

Trish Gorely (T)

Department of Nursing and Midwifery, University of the Highlands and Islands, Centre for Health Sciences, Inverness, UK.

Shahina Pardhan (S)

Vision and Eye Research Institute (VERI), School of Medicine, Anglia Ruskin University, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH